Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nayeon Shim"'
Autor:
Jinseong Kim, Man Kyu Shim, Yujeong Moon, Jeongrae Kim, Hanhee Cho, Wan Su Yun, Nayeon Shim, Joon-Kyung Seong, Yonghyun Lee, Dong-Kwon Lim, Kwangmeyung Kim
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-19 (2024)
Abstract Background Immunogenic cell death (ICD) is a crucial approach to turn immunosuppressive tumor microenvironment (ITM) into immune-responsive milieu and improve the response rate of immune checkpoint blockade (ICB) therapy. However, cancer cel
Externí odkaz:
https://doaj.org/article/d7fec239545c4da894e316023dafcba6
Autor:
Youngjoo Lee, Sukyung Song, Suah Yang, Jinseong Kim, Yujeong Moon, Nayeon Shim, Hong Yeol Yoon, Sehoon Kim, Man Kyu Shim, Kwangmeyung Kim
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 3, Pp 1428-1440 (2024)
Immune checkpoint blockade (ICB) therapy targeting PD-L1 via monoclonal antibody (mAb) has shown extensive clinical benefits in the diverse types of advanced malignancies. However, most patients are completely refractory to ICB therapy owing to the P
Externí odkaz:
https://doaj.org/article/2f89f6cef0a14225924ae8e3cde451f8
Autor:
Man Kyu Shim, Suah Yang, Jooho Park, Jun Sik Yoon, Jinseong Kim, Yujeong Moon, Nayeon Shim, Mihee Jo, Yongwhan Choi, Kwangmeyung Kim
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Nanomedicine has emerged as a promising strategy for cancer treatment. The most representative nanomedicine used in clinic is PEGylated liposomal doxorubicin DOXIL®, which is first FDA-approved nanomedicine. However, several shor
Externí odkaz:
https://doaj.org/article/1d964f4c8c194484a709a371bc75bf02
Autor:
Yi Zhao, Nayeon Shim, Yan-Hong Cui, Jae-Hyeok Kang, Ki-Chun Yoo, Seungmo Kim, Joo Mi Yi, Min-Jung Kim, Jai Hoon Yoon, Su-Jae Lee
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-4 (2021)
Externí odkaz:
https://doaj.org/article/b099222e375145fc8ff3a03c7b488e76
Autor:
Jeongrae Kim, Yongwhan Choi, Suah Yang, Jaewan Lee, Jiwoong Choi, Yujeong Moon, Jinseong Kim, Nayeon Shim, Hanhee Cho, Man Kyu Shim, Sangmin Jeon, Dong-Kwon Lim, Hong Yeol Yoon, Kwangmeyung Kim
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 474 (2022)
Immunogenic cell death (ICD) is a powerful trigger eliciting strong immune responses against tumors. However, traditional chemoimmunotherapy (CIT) does not last long enough to induce sufficient ICD, and also does not guarantee the safety of chemother
Externí odkaz:
https://doaj.org/article/43e2445e935f492f9acd0bf5364d94ef
Autor:
Nayeon Shim, Seong Ik Jeon, Suah Yang, Jung Yeon Park, Mihee Jo, Jinseong Kim, Jiwoong Choi, Wan Su Yun, Jeongrae Kim, Youngjoo Lee, Man Kyu Shim, Yongju Kim, Kwangmeyung Kim
Publikováno v:
Biomaterials. 289:121806
A carrier-free prodrug nanoparticle has emerged as a potential approach to cancer therapy. It plays a vital role in enhancing the tumor targeting and therapeutic efficacy of the anticancer agent at sites of intention wherein the prodrug nanoparticle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03f8080e71ac81daadc3c67ffcc70d77
https://doi.org/10.1016/j.biomaterials.2022.121806
https://doi.org/10.1016/j.biomaterials.2022.121806
Publikováno v:
Environmental Nanotechnology, Monitoring & Management. 17:100653
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::370408014b07d0ff0d25a6fbb2dd1c58
https://doi.org/10.1016/j.enmm.2022.100653
https://doi.org/10.1016/j.enmm.2022.100653